HCW Biologics Inc (HCWB)
1.12
-0.01
(-0.88%)
USD |
NASDAQ |
May 13, 15:40
HCW Biologics Gross Profit Margin (Quarterly): 19.08% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.08% |
| September 30, 2023 | 20.49% |
| June 30, 2023 | 19.33% |
| March 31, 2023 | 29.92% |
| Date | Value |
|---|---|
| December 31, 2022 | 20.00% |
| September 30, 2022 | 20.00% |
| June 30, 2022 | 36.74% |
| March 31, 2022 | 57.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
19.08%
Minimum
Dec 2023
57.40%
Maximum
Mar 2022
27.87%
Average
20.24%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -91.92% |
| Return on Assets | -64.43% |
| Return on Invested Capital | -74.50% |
| Profit Margin (Quarterly) | -806.7% |
| Operating Margin (Quarterly) | -813.3% |
| Return on Net Operating Assets | -146.1% |